MDMA/MDA Screen, with Confirmation, Urine
Use
This test performs an initial immunoassay-based screen for MDMA (ecstasy) and its metabolite MDA in urine; presumptive positive results are reflexed to confirmation testing using more specific and sensitive mass spectrometry methods such as LC–MS/MS. It is useful for detecting stimulant use in clinical, employment, or monitoring contexts.
Special Instructions
Not explicitly provided; presumed standard urine collection without additional preparation instructions as per analogous descriptions.
Limitations
Quantitative values cannot be used to infer dose because drugs like MDMA are extensively metabolized and excreted; only qualitative interpretation relative to cutoff values is appropriate.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided